Get In Touch

Disease-Modifying Antirheumatic Drug (DMARD) Market: Introduction

  • Disease-modifying antirheumatic drugs (DMARDs) are a class of drugs utilized as a therapy for inflammatory arthritis, including psoriatic arthritis (PsA), rheumatoid arthritis (RA), and ankylosing spondylitis (AS). They are also indicated for the treatment of other disorders such as connective tissue disease including systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and Sjogren syndrome (SS), along with the treatment of vasculitis, uveitis, inflammatory myositis, inflammatory bowel disease, etc.
  • The disease-modifying antirheumatic drug (DMARD) market can be segmented based on drug type, distribution channel, route of administration, indication, and region. Based on drug type, the disease-modifying antirheumatic drug (DMARD) market can be classified into Synthetic (sDMARD), Targeted synthetic DMARDs (tsDMARDs), Biological DMARDs (bDMARD) and others. The Synthetic (sDMARD) segment can be further sub-segmented into Conventional synthetic (csDMARDs) sub-segment, which can be further split into Methotrexate, Sulfasalazine, Leflunomide, Hydroxychloroquine and gold salts. While the Biological DMARDs (bDMARD) segment can be further categorized into Original DMARDs (boDMARDs) and Biosimilar DMARDs (bsDMARDs). The Biosimilar DMARDs (bsDMARDs) sub-segment can be split into primary, secondary & tertiary. Based on indication, the market can be categorized into ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus, and others. In terms of distribution channel, the market can be split into hospital pharmacies, retail pharmacies, and e-commerce. In terms of route of administration, the disease-modifying antirheumatic drug (DMARD) market can be segregated into oral, parenteral, and others.

Key Drivers, Restraints, and Opportunities of Global Disease-Modifying Antirheumatic Drug (DMARD) Market

  • Launch of novel biosimilar, rising prevalence of arthritis, and an increase in the acceptance of biopharmaceuticals are major factors fueling the disease-modifying antirheumatic drug market. Furthermore, raising burden of rheumatoid arthritis disease coupled with a rise in geriatric population is also driving the market. Arthritis generally impacts the geriatric population, and the prevalence is observed higher in females. Thus, larger cases of this disease could be observed in the geriatric population, which is further boosting the market.
  • Various medication are being developed for the treatment of rheumatoid arthritis since the last few years. Thus, an increase in alternatives and awareness about safer drugs are further driving the global disease-modifying antirheumatic drug market.
  • Moreover, enhanced diagnostic procedures are also boosting the global market for disease-modifying antirheumatic drugs. Additionally, the market is anticipated to expand due to the transmission of several awareness programs and a rise in number of skilled healthcare professionals. In 2017, AbbVie Inc. was a leader in the global disease-modifying antirheumatic drugs market. Nevertheless, various leading companies are focused on investing on research and development of novel medicines in consolidate their presence in the market.

Asia Pacific to Capture Major Share of Global Disease-Modifying Antirheumatic Drug (DMARD) Market

  • The market in Asia Pacific is anticipated to expand at a significant growth rate during the forecast period, owing to rising healthcare expenditure. However, the lower cost of manufacturing in China and India has resulted in an increase in manufacturing facilities, attracting numerous pharmaceutical and biotechnological companies to Asia Pacific.
  • Rise in cases of rheumatoid arthritis disease is also estimated to fuel the market in the region during the forecast period. For instance, as per the statistics of Institute for Health Metrics and Evaluation, the cases of rheumatoid arthritis have increased from 183,272 in 2007 to 263,365 in 2017 only in India. Thus, observing the number of cases in other significant countries of Asia Pacific, the healthcare activities concerned with the treatment of rheumatoid arthritis would require continuous support from everyone.
  • North America follows Asia Pacific in terms of share of the global market. The market in the region is expected to expand at a higher growth rate during the forecast period owing to an increase in research and development activities toward the development of novel therapies for rheumatoid arthritis. Moreover, the presence of leading industry players is also projected to fuel the market in the region.

Key Players Operating in Global Disease-Modifying Antirheumatic Drug (DMARD) Market

The global disease-modifying antirheumatic drug (DMARD) market is highly fragmented, with the presence of various key players. A large number of manufacturers hold a major share in their respective regions. Major players operating in the global disease-modifying antirheumatic drug (DMARD) market are:

  • Sanofi SA
  • Pfizer Inc.
  • F. Hoffman-La Roche AG
  • Johnson & Johnson
  • AbbVie Inc.
  • Eli Lilly & Company
  • Amgen Inc.
  • Sobi Inc.
  • Bristol-Myers Squibb Company
  • UCB S.A.

Global Disease-Modifying Antirheumatic Drug (DMARD) Market: Research Scope

Global Disease-Modifying Antirheumatic Drug (DMARD) Market, by Drug Type

  • Synthetic (sDMARD)
    • Conventional synthetic (csDMARDs)
      • Methotrexate
      • Sulfasalazine
      • Leflunomide
      • Hydroxychloroquine
      • Gold Salts
  • Targeted synthetic DMARDs (tsDMARDs)
  • Biological DMARDs (bDMARD)
    • Original DMARDs (boDMARDs)
    • Biosimilar DMARDs (bsDMARDs)
      • Primary
      • Secondary
      • Tertiary
  • Others

Global Disease-Modifying Antirheumatic Drug (DMARD) Market, by Route of Drug Administration

  • Oral
  • Parenteral
  • Others

Global Disease-Modifying Antirheumatic Drug (DMARD) Market, by Indication

  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Systemic Lupus Erythematosus
  • Others

Global Disease-Modifying Antirheumatic Drug (DMARD) Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E Commerce

Global Disease-Modifying Antirheumatic Drug (DMARD) Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East &Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Disease Modifying Anti Rheumatic Drugs Market

Pre Book